Patents by Inventor Pierre Fouret

Pierre Fouret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MSH2 AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER
    Publication number: 20120004136
    Abstract: The invention is generally directed to a diagnostic method for predicting the benefit of the response of a subject diagnosed with cancer to a platinum compound-based adjuvant chemotherapy, preferably to a cisplatin-based chemotherapy which implements the determination of the MSH2 expression level in the biological sample containing tumor cells, and, optionally, the ERCC1 expression level.
    Type: Application
    Filed: March 19, 2010
    Publication date: January 5, 2012
    Applicant: INSTITUT GUSTAVE-ROUSSY
    Inventors: Pierre Fouret, Jean-Charles Soria
  • ERCC1 EXPRESSION IN PREDICTING RESPONSE FOR CANCER CHEMOTHERAPY
    Publication number: 20090215090
    Abstract: The present invention concerns an in vitro method for detecting the susceptibility of a tumor cell to a chemotherapy, said method comprising the step of the measurement of the ERCC1 protein by immunohistochemistry in a formalin-fixed paraffin-embedded tumor sample.
    Type: Application
    Filed: March 14, 2007
    Publication date: August 27, 2009
    Inventors: Pierre Fouret, Jean-Charles Soria